Reduced acute rejection and side effects with neoral in liver transplantation.
Tisone
G
G
Centro Trapianti d'Organo, Clinica Chirurgica, Università di Roma Tor Vergata, Ospedale S. Eugenio, Italy.
Vennarecci
G
G
Pisani
F
F
Baiocchi
L
L
Mercadante
E
E
Orlando
G
G
Anselmo
A
A
Casciani
C U
CU
D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007275:Injections, Intravenous; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone